# Prochlorperazine Edisylate

NDC: 0713-0351
Generic name: Prochlorperazine Edisylate
Labeler / Manufacturer: Cosette Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20220211

FDA application: ANDA213626

## Active ingredients

- PROCHLORPERAZINE EDISYLATE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0713-0351"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0713-0351
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4687b9f5-2d67-4fe0-af4d-2415a42b5292